These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2470425)

  • 41. Regional neurotransmitter responses after acute and chronic electroconvulsive shock.
    Glue P; Costello MJ; Pert A; Mele A; Nutt DJ
    Psychopharmacology (Berl); 1990; 100(1):60-5. PubMed ID: 1688661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep deprivation in the rat: XVIII. Regional brain levels of monoamines and their metabolites.
    Bergmann BM; Seiden LS; Landis CA; Gilliland MA; Rechtschaffen A
    Sleep; 1994 Oct; 17(7):583-9. PubMed ID: 7531362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat.
    Finklestein S; Campbell A; Stoll AL; Baldessarini RJ; Stinus L; Paskevitch PA; Domesick VB
    Brain Res; 1983 Jul; 271(2):279-88. PubMed ID: 6193832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional brain monoamines and their metabolites after portacaval shunting.
    Mans AM; Consevage MW; DeJoseph MR; Hawkins RA
    Metab Brain Dis; 1987 Sep; 2(3):183-93. PubMed ID: 2463462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of repeated dietary exposure of aflatoxin B1 on brain biogenic amines and metabolites in the rat.
    Coulombe RA; Sharma RP
    Toxicol Appl Pharmacol; 1985 Sep; 80(3):496-501. PubMed ID: 2412309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phasic alterations in dopamine metabolites following continuous administration of amphetamine.
    Ellison G
    Brain Res; 1983 Jun; 268(2):387-9. PubMed ID: 6191836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the mechanism of action of caroxazone, a new antidepressant drug.
    Moretti A; Caccia C; Calderini G; Menozzi M; Amico A
    Biochem Pharmacol; 1981 Oct; 30(19):2728-31. PubMed ID: 6170295
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in biogenic amines in rat hippocampus during development and aging.
    Santiago M; Machado A; Reinoso-Suárez F; Cano J
    Life Sci; 1988; 42(24):2503-8. PubMed ID: 2453775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regional changes in monoamine metabolism in the aging constant estrous rat.
    Simpkins JW
    Neurobiol Aging; 1984; 5(4):309-13. PubMed ID: 6085135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin depression of local cerebral glucose utilisation after monoamine oxidase inhibition.
    Grome JJ; Harper AM
    J Cereb Blood Flow Metab; 1985 Sep; 5(3):473-5. PubMed ID: 4030926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment.
    Handa RJ; Hejna GM; Lorens SA
    Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment.
    Song C; Merali Z; Anisman H
    Neuroscience; 1999; 88(3):823-36. PubMed ID: 10363820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of idebenone (CV-2619) on metabolism of monoamines, especially serotonin, in the brain of normal rats and rats with cerebral ischemia.
    Narumi S; Nagai Y; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y
    Jpn J Pharmacol; 1985 Mar; 37(3):235-44. PubMed ID: 2582171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction.
    Dellu-Hagedorn F; Fitoussi A; De Deurwaerdère P
    J Neurosci Methods; 2017 Mar; 280():54-63. PubMed ID: 28161298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortex.
    Twist EC; Mitchell SN; Corn TH; Campbell IC
    Eur J Pharmacol; 1991 Apr; 196(2):157-60. PubMed ID: 1908389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
    Thiblin I; Finn A; Ross SB; Stenfors C
    Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.